Answers are grounded in this paper and cite their sources.
In a multicentre double-blind randomized parallel-group study, 48 patients with mycologically proven tinea pedis were treated with either oncedaily applications of terbinafine 1% cream or placebo for 2 weeks. The mycological cure rate at follow-up 4 weeks after completing treatment, was 81% for terbinafine compared with 45% for placebo (P = 0.01, Fisher's exact test, one tailed). Only one adverse event, an erythematous rash in a terbinafine-treated patient, was thought to be related to treatment. Topical terbinafine 1% cream used once daily for 2 weeks was shown to be an effective and well-tolerated treatment for tinea pedis.
No takes yet. Share an insight, caveat, or question.
Evans et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: